ATE88277T1 - Gegen eine substanz mit niedrigem molekulargewicht spezifischer antikoerper und verfahren zu seiner herstellung mittels kolloidaler metallteilchen als traeger. - Google Patents

Gegen eine substanz mit niedrigem molekulargewicht spezifischer antikoerper und verfahren zu seiner herstellung mittels kolloidaler metallteilchen als traeger.

Info

Publication number
ATE88277T1
ATE88277T1 AT87100208T AT87100208T ATE88277T1 AT E88277 T1 ATE88277 T1 AT E88277T1 AT 87100208 T AT87100208 T AT 87100208T AT 87100208 T AT87100208 T AT 87100208T AT E88277 T1 ATE88277 T1 AT E88277T1
Authority
AT
Austria
Prior art keywords
molecular weight
substance
metal particles
colloidal metal
carrier
Prior art date
Application number
AT87100208T
Other languages
English (en)
Inventor
Shiosaka Sadao
Johji Kohno
Hiroshi Kiyama
Masaya Tohyama
Yahe Shiotani
Original Assignee
Shiosaka Sadao
Johji Kohno
Hiroshi Kiyama
Masaya Tohyama
Yahe Shiotani
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shiosaka Sadao, Johji Kohno, Hiroshi Kiyama, Masaya Tohyama, Yahe Shiotani filed Critical Shiosaka Sadao
Application granted granted Critical
Publication of ATE88277T1 publication Critical patent/ATE88277T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6806—Determination of free amino acids
    • G01N33/6812—Assays for specific amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • G01N33/553—Metal or metal coated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Colloid Chemistry (AREA)
AT87100208T 1986-01-10 1987-01-09 Gegen eine substanz mit niedrigem molekulargewicht spezifischer antikoerper und verfahren zu seiner herstellung mittels kolloidaler metallteilchen als traeger. ATE88277T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP61003825A JPS62162963A (ja) 1986-01-10 1986-01-10 金属コロイド粒子を担体とする低分子物質に対する特異抗体の作成法
EP87100208A EP0232717B1 (de) 1986-01-10 1987-01-09 Gegen eine Substanz mit niedrigem Molekulargewicht spezifischer Antikörper und Verfahren zu seiner Herstellung mittels kolloidaler Metallteilchen als Träger

Publications (1)

Publication Number Publication Date
ATE88277T1 true ATE88277T1 (de) 1993-04-15

Family

ID=11567970

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87100208T ATE88277T1 (de) 1986-01-10 1987-01-09 Gegen eine substanz mit niedrigem molekulargewicht spezifischer antikoerper und verfahren zu seiner herstellung mittels kolloidaler metallteilchen als traeger.

Country Status (6)

Country Link
US (1) US5112606A (de)
EP (1) EP0232717B1 (de)
JP (1) JPS62162963A (de)
AT (1) ATE88277T1 (de)
DE (1) DE3785374T2 (de)
ES (1) ES2054621T3 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972656A (en) * 1989-03-14 1999-10-26 Bionebraska, Inc. Mercury binding polypeptides and nucleotides coding therefore
US5639624A (en) * 1989-03-14 1997-06-17 Board Of Regents Of The University Of Nebraska Monoclonal antibodies specific for metallic cations and method therefor
AU8499691A (en) * 1990-09-05 1992-03-30 Neurex Corporation Method and composition for detecting bioactive peptides
JP3183666B2 (ja) * 1991-07-19 2001-07-09 アツセイ・リサーチ・インコーポレーテツド 内因性サイトカイン類の測定方法およびキット
US5965379A (en) * 1991-07-19 1999-10-12 Cytimmune Sciences Inc. Method for measuring endogenous cytokines
US5679350A (en) * 1992-05-28 1997-10-21 The University Of Toledo Method of delivery of a medicament to a cancer cell using a pathway of plasminogen activator material
DE69433870T2 (de) * 1993-03-18 2005-06-30 Cytimmune Sciences, Inc. Zusammensetzung und methode zur reduktion der toxizität von biologisch-aktiven faktoren
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
US5532136A (en) * 1993-06-22 1996-07-02 Bionebraska, Inc. Monoclonal antibody assay and kit for detecting metal cations in body fluids
US20010055581A1 (en) * 1994-03-18 2001-12-27 Lawrence Tamarkin Composition and method for delivery of biologically-active factors
US6111079A (en) * 1995-06-05 2000-08-29 Bionebraska, Inc. Lead binding polypeptides and nucleotides coding therefore
DE69723580T2 (de) * 1996-05-03 2004-06-03 Thomas Jefferson University Impfstoff gegen metastasierenden kolorektalkrebs.
US7135333B1 (en) 1997-08-07 2006-11-14 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US6120995A (en) * 1997-08-07 2000-09-19 Thomas Jefferson University Compositions that specifically bind to colorectal cancer cells and methods of using the same
US7229841B2 (en) * 2001-04-30 2007-06-12 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
ATE317269T1 (de) * 1997-11-10 2006-02-15 Cytimmune Sciences Inc Methoden und zusammensetzungen zur erhöhung der immunantwort und zur herstellung von in-vitro monoklonalen antikörpern (mabs)
US6407218B1 (en) 1997-11-10 2002-06-18 Cytimmune Sciences, Inc. Method and compositions for enhancing immune response and for the production of in vitro mabs
US20020012931A1 (en) 2000-03-27 2002-01-31 Waldman Scott A. High specificity marker detection
WO2002022885A1 (en) * 2000-09-18 2002-03-21 Thomas Jefferson University Compositions and methods for identifying and targeting stomach and esophageal cancer cells
WO2004000217A2 (en) 2002-06-20 2003-12-31 The Trustees Of The University Of Pennsylvania Vaccines for suppressing ige-mediated allergic disease and methods for using the same
JP2008504216A (ja) * 2003-12-02 2008-02-14 サイトイミューン サイエンシズ インコーポレイテッド モノクローナル抗体の生成のための方法および組成物
JP4833862B2 (ja) * 2004-01-28 2011-12-07 サイトイミューン サイエンシズ インコーポレイテッド 官能化コロイド金属組成物および方法
JP4735954B2 (ja) * 2005-06-03 2011-07-27 独立行政法人産業技術総合研究所 抗体産生キャリア
US20080206276A1 (en) * 2005-07-08 2008-08-28 Michael Otto Targeting Poly-Gamma-Glutamic Acid to Treat Staphylococcus Epidermidis and Related Infections
CN102203002A (zh) * 2007-09-21 2011-09-28 细胞免疫科学公司 纳米治疗性胶态金属组合物和方法
US20110014118A1 (en) * 2007-09-21 2011-01-20 Lawrence Tamarkin Nanotherapeutic colloidal metal compositions and methods
US7960145B2 (en) * 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
US20110206736A1 (en) * 2008-09-23 2011-08-25 Thomas Jefferson University Cancer Vaccines Against Mucosal Antigens and Methods of Making and Using the Same
DE102009040870B4 (de) * 2009-09-09 2016-10-13 Manfred Sietz Modifiziertes kolloidales Edelmetall zur Behandlung und Prophylaxe von Krankheiten
EP2491116A4 (de) 2009-10-22 2013-12-11 Univ Jefferson Zellbasierte antikrebszusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
CA2919907A1 (en) 2012-08-02 2014-02-06 The Board Of Trustees Of The Leland Stanford Junior University Peptide vaccines based on the egfrviii sequence for the treatment of tumors

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1492010A1 (de) * 1961-10-06 1969-07-17 Mack Chem Pharm Verfahren zur Herstellung von zur Desensibilisierung von Allergosen geeigneten Stoffen
GB981242A (en) * 1961-10-19 1965-01-20 Wellcome Found Vaccines containing rare earth salts
DE1945251A1 (de) * 1969-09-06 1971-03-11 Karl Dr Med Theurer Verfahren zur Beeinflussung der quantitativen Antikoerperbildung bei der aktiven Immunisierung und der Desensibilisierung
US4016252A (en) * 1972-04-06 1977-04-05 Institut Pasteur Calcium phosphate gel for adsorbing vaccines
US4197237A (en) * 1973-06-01 1980-04-08 Syva Company Antibodies to nitrogen derivatives of benzoyl ecgonine antigenic conjugates thereof
US3919413A (en) * 1973-10-12 1975-11-11 Univ Nebraska Vaccine for neonatal calf diarrhea
US4218436A (en) * 1977-09-21 1980-08-19 The Upjohn Company Compounds and methods
US4197286A (en) * 1977-09-27 1980-04-08 Southwest Research Institute Testosterone derivatives and assay method
US4196185A (en) * 1978-06-05 1980-04-01 Hoffmann-La Roche Inc. Immunoassay for phencyclidine
US4329281A (en) * 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4215036A (en) * 1978-08-15 1980-07-29 Research Corporation Modified grass pollen antigens
CA1133829A (en) * 1978-08-24 1982-10-19 Neil J.L. Gilmour Pasteurellosis vaccines
US4213964A (en) * 1978-12-07 1980-07-22 Miles Laboratories, Inc. Diphenylhydantoin antibodies
US4332787A (en) * 1980-06-23 1982-06-01 The Massachusetts General Hospital Assay for beta-adrenergic antagonists and antibody therefor
US4608252A (en) * 1981-04-23 1986-08-26 Syntex (U.S.A.) Inc. Chloramphenicol derivatives antigens and antibodies
FR2533827A1 (fr) * 1982-09-30 1984-04-06 Anvar Composition possedant des proprietes immunoregulatrices, notamment d'adjuvants immunologiques non specifiques, a base de muramylpeptide et d'un derive d'aluminium
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
NO162241C (no) * 1983-06-14 1989-11-29 Roussel Uclaf Nye, radioaktive estradienderivater merket med jod125, fremgangsmaate ved deres fremstilling og deres anvendelse vedradioimmunologisk undersoekelse og mengdebestemmelse av steroider i biologiske vaesker.
JPS60193925A (ja) * 1984-03-13 1985-10-02 Chemo Sero Therapeut Res Inst 凍結乾燥製剤化ワクチン

Also Published As

Publication number Publication date
EP0232717A3 (en) 1989-02-15
JPH0584467B2 (de) 1993-12-02
DE3785374T2 (de) 1993-10-14
EP0232717B1 (de) 1993-04-14
EP0232717A2 (de) 1987-08-19
US5112606A (en) 1992-05-12
JPS62162963A (ja) 1987-07-18
DE3785374D1 (de) 1993-05-19
ES2054621T3 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
ATE88277T1 (de) Gegen eine substanz mit niedrigem molekulargewicht spezifischer antikoerper und verfahren zu seiner herstellung mittels kolloidaler metallteilchen als traeger.
GB1475125A (en) Immunological detection
Yguerabide et al. Segmental flexibility in an antibody molecule
ATE50647T1 (de) Verfahren zur quantifizierung von zellpopulationen bzw. subpopulationen sowie hierfuer geeignetes reagenz.
ES440173A1 (es) Un metodo para determinar en una solucion de ensayo la pre- sencia de un ligando.
ATE10548T1 (de) Verfahren der konzentrierten zone in heterogenen immunoassays.
DE2654723A1 (de) Magnetisches gel fuer immunoenzymatische bestimmungen
KR890702038A (ko) 인간 혈청에서의 hiv 항원 검출용 효소 면역 분석법
EP0162914A1 (de) Neue immunoteste und sätze zur verwendung in denselben.
ATE15274T1 (de) Verfahren und ausruestung zum testen von antikoerpern gegen loesliche antigene.
ATE177533T1 (de) Verfahren zur bestimmung einer immunologischen aktiven substanz mittels magnetischer latexteilchen und nichtmagnetischer teilchen
ES444543A1 (es) Metodo de determinacion inmunologica.
CN107955069B (zh) 一种改进的重金属铅人工抗原的合成方法及dota在制备重金属铅人工抗原试剂中的用途
AU4032095A (en) Immunoassays for haptens and hapten tracer-antibody complex which can be used therefor, and process for the preparation thereof
Breyer et al. A polarographic investigation of the binding properties of serum albumin
DE59106634D1 (de) Pankreas-elastase-1-spezifischer antikörper, ein verfahren zu seiner gewinnung und ein testkit der solche antikörper enthält.
Hauser et al. Localisation by immunological techniques of myosin in nuclei of lower eukaryotes
Bibring et al. Immunochemical studies of 22S protein from isolated mitotic apparatus
KR850008620A (ko) Atl 바이러스 항체의 측정방법 및 시약
ATE122150T1 (de) Einschritt-immuntest zur bestimmung von antigen- spezifischen antikörpern aller immunglobulin- klassen und dazu geeignetes mittel.
Kitano et al. Direct observation of association processes between polymer latex particles
SU641320A1 (ru) Способ неразрушающего контрол прочности изделий
FI843562A0 (fi) Foerfarande foer immunokemisk bestaemning av hepatitis b kaernantigener.
JPS5544903A (en) Method of quantitatively analyzing low molecular substance in humor
FI904304A0 (fi) Foerfarande foer paovisande av analyter.